Blake Aftab

Company: Adicet Bio Inc.

Job title: Chief Scientific Officer

Seminars:

Industry Leaders’ Fireside Chat: Allogeneic Therapies Take on Europe 8:45 am

Reviewing clinical and preclinical trials in European allogeneic cell therapies to highlight developmental benefits Touching on the unique challenges of the European field, including market access, regulatory and capacity difficulties, to reveal the practical and strategic considerations for successful development Celebrating European allogeneic advances to encourage further expansion of the fieldRead more

day: Day One

Designing Therapies for Solid Tumour Indications to Enhance Efficacy in the Microenvironment In Vivo 3:30 pm

Overview of first-in-class learnings for gamma-delta CAR-T cells Discuss areas for further leveraging, enhancing, and targeting gamma-delta T cells in solid malignancies Reprogramming innate signalling capabilities to augment potency for gammadelta T cells in solid tumoursRead more

day: Day One